BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
SIRT1
,
nitric oxide metabolic process
,
Hepatitis
,
Breast
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cml cd34(+) cells
Summary
General Info
Curated Studies
Most Correlated Studies
Gene expression of CML CD34+ cells during imatinib therapy
Gene expression profiling of CD34+ subsets in CML and healthy individuals
Leukemic cells in defined cell cycle states from chronic myelogenous leukemia (CML) patients
Transcriptome profiling of untreated and fenretinide-treated CD34+ cells from 4 CML patients
CD34+ cells of chronic phase chronic myeloid leukemia (CML) patients treated with imatinib
Explore Curated Studies Results
Literature
Most Relevant Literature
Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by bloc…
Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to C…
Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression p…
BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progen…
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyeloc…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cel…
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, A…
Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological …
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ